Formulations of Bendamustine (2013)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application 61/613,173, filed Mar 20, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,000,021 | Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,034,908 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,144,568 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,572,887 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,572,888 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,579,384 | Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,597,397 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,597,398 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 9,597,399 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,052,385 | Formulations of Bendamustine In force · High confidence | Eagle Pharmaceuticals, Inc. | In force | High confidence | ||
| 15 more patents in this group · Pro | ||||||
10 of 25 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 25.
10 of these are in force and held by Eagle Pharmaceuticals, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.